Drug Type Chemical drugs |
Synonyms nano ZSA 51D, nano ZSA51D |
Target |
Action agonists |
Mechanism STING agonists(Stimulator of interferon genes agonists) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Cancer | Preclinical | United States | 27 Apr 2025 | |
Colonic Cancer | Preclinical | United States | 22 Mar 2024 |